Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resfenol for Common Cold and Flu Symptoms
NCT01158326Phase 3Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Aug 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in common cold and influenza comparing Resfenol Arm with Placebo Arm (2 arms). Primary endpoint: Reduction in Global Symptom Score at 48 hours. Started Aug 2010; status: completed.
02
Drugs
Resfenol
03
Conditions
common coldinfluenza
Beyond the preview
Go deeper on NCT01158326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01158326.